These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17961529)

  • 1. No certain predictors for mutation status in a Danish cohort with familial hypercholesterolemia: a descriptive study.
    Nybo M; Brusgaard K; Hansen AB
    Clin Biochem; 2007 Dec; 40(18):1347-52. PubMed ID: 17961529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.
    Jansen AC; van Aalst-Cohen ES; Tanck MW; Cheng S; Fontecha MR; Li J; Defesche JC; Kastelein JJ
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1475-81. PubMed ID: 15879303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
    Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
    Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic analysis of 1053 Danish individuals with clinical signs of familial hypercholesterolemia.
    Brusgaard K; Jordan P; Hansen H; Hansen AB; Hørder M
    Clin Genet; 2006 Mar; 69(3):277-83. PubMed ID: 16542394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic screening for familial hypercholesterolemia in 1992-1997: primarily younger patients in the care of family physicians].
    ten Asbroek AH; van Lunsen S; Marang-van de Mheen PJ; Gunning-Schepers LJ
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):125-9. PubMed ID: 10674119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for familial hypercholesterolemia: what is the most effective strategy?
    Daniels SR
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):130-1. PubMed ID: 18059381
    [No Abstract]   [Full Text] [Related]  

  • 8. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia.
    Guardamagna O; Restagno G; Rolfo E; Pederiva C; Martini S; Abello F; Baracco V; Pisciotta L; Pino E; Calandra S; Bertolini S
    J Pediatr; 2009 Aug; 155(2):199-204.e2. PubMed ID: 19446849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.
    Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M
    Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
    Koeijvoets KC; Mooijaart SP; Dallinga-Thie GM; Defesche JC; Steyerberg EW; Westendorp RG; Kastelein JJ; van Hagen PM; Sijbrands EJ
    Eur Heart J; 2009 Mar; 30(5):618-23. PubMed ID: 19098018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
    Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
    J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing familial hypercholesterolaemia: the relevance of genetic testing.
    van Aalst-Cohen ES; Jansen AC; Tanck MW; Defesche JC; Trip MD; Lansberg PJ; Stalenhoef AF; Kastelein JJ
    Eur Heart J; 2006 Sep; 27(18):2240-6. PubMed ID: 16825289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia.
    Silva PR; Jannes CE; Marsiglia JD; Krieger JE; Santos RD; Pereira AC
    Atherosclerosis; 2016 Jul; 250():144-50. PubMed ID: 27214396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Being at risk for cardiovascular disease: perceptions and preventive behavior in people with and without a known genetic predisposition.
    Claassen L; Henneman L; van der Weijden T; Marteau TM; Timmermans DR
    Psychol Health Med; 2012; 17(5):511-21. PubMed ID: 22360457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE.
    Paquette M; Brisson D; Dufour R; Khoury É; Gaudet D; Baass A
    J Clin Lipidol; 2017; 11(5):1161-1167.e3. PubMed ID: 28801029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic family screening for familial hypercholesterolemia in Iceland.
    Thorsson B; Sigurdsson G; Gudnason V
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):335-8. PubMed ID: 12588780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter hyperintensities on T2-weighted MRI images among DNA-verified older familial hypercholesterolemia patients.
    Hyttinen L; Autti T; Rauma S; Soljanlahti S; Vuorio AF; Strandberg TE
    Acta Radiol; 2009 Apr; 50(3):320-6. PubMed ID: 19229678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cox proportional hazards models have more statistical power than logistic regression models in cross-sectional genetic association studies.
    van der Net JB; Janssens AC; Eijkemans MJ; Kastelein JJ; Sijbrands EJ; Steyerberg EW
    Eur J Hum Genet; 2008 Sep; 16(9):1111-6. PubMed ID: 18382476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.